As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

Widespread use of contemporary antiretroviral therapy globally has transformed HIV
disease into a chronic illness associated with excess risk for disorders of the heart and …

HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

Background People living with HIV (PLWH) experience higher risk of myocardial infarction
(MI) and heart failure (HF) compared with uninfected individuals. Risk of other …

Transthyretin amyloid cardiomyopathy, an often unrecognized cause of heart failure, is now
treatable with a transthyretin stabilizer. It is therefore important to identify at-risk patients who …

Cardiac abnormalities were identified early in the epidemic of AIDS, predating the isolation
and characterization of the etiologic agent, HIV. Several decades later, the causation and …

People with HIV (PWH) are at elevated risk for cardiovascular diseases (CVDs), including
myocardial infarction, heart failure, and sudden cardiac death, among other CVD …

Objectives The purpose of this study was to compare the risks of incident heart failure (HF)
among a variety of chronic inflammatory diseases (CIDs) and to determine whether risks …

Contemporary World Health Organization data indicates that≈ 39 million people are living
with the human immunodeficiency virus. Of these, 24 million have been reported to have …

Background A recent observational study suggested that the risk of cardiovascular events
could be higher among antiretroviral therapy (ART)-naive individuals with HIV who receive …